Ringing the changes: how bacterial enzymes convert ribosomally-synthesised peptides into antibiotics
In plain English
AI plain-English summaryBacterial YcaO enzymes are being turned into molecular assembly lines to produce new antibiotics. These enzymes are essential for building several classes of natural antibiotics, but scientists do not yet understand how they work or how their activity is coordinated inside multi-protein complexes. Without this knowledge, researchers cannot reliably repurpose YcaOs to create artificial peptide drugs. This project will use cryo-electron microscopy and X-ray crystallography to capture snapshots of YcaO enzymes trapped at different stages of their catalytic cycle. The researcher will also discover new YcaO variants to expand the known chemical reactions they can perform. Because YcaOs are promiscuous—they accept many different peptide sequences—the team will co-express randomised precursor genes alongside modification systems to generate large libraries of potential antibiotics. These will be screened using a high-throughput platform where nano-sized hydrogel beads, each containing a producer and a reporter bacterial strain, are sorted by fluorescence-activated cell sorting. This is fundamental science. It will not produce a market-ready drug tomorrow. But understanding how YcaOs build antibiotic scaffolds could eventually enable the rational design of entirely new classes of antimicrobials, addressing the growing crisis of drug-resistant infections.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Residual AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know